← Back to Search

Diagnostic Test

BioFire® Respiratory Panel 2.1-EZ for Viral Infections (URGENT Trial)

N/A
Waitlist Available
Led By Andrew Meltzer, MD
Research Sponsored by Andrew Meltzer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 7 after enrollment
Awards & highlights

Summary

This trial is testing a rapid PCR test to see if it can improve patient and provider-reported outcomes for people with symptomatic upper respiratory infections.

Eligible Conditions
  • Viral Infections
  • Acute Respiratory Infection
  • Common Cold

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 7 after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Missed Time at Work or School
Need for Additional Diagnostic Tests by Participants Family Members / Close Contacts
Need for Additional Diagnostic Tests by Patient
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BioFire® Respiratory Panel 2.1-EZExperimental Treatment1 Intervention
EXP group will receive the BioFire RP2.1-EZ panel, designed to test for a variety of bacterial and/or viral causes for illness
Group II: Standard of CareActive Control1 Intervention
Standard care procedures are essentially yes/no to patient having SARS-COV-2, the SC group will receive the standard nasal swab used in the IPCs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BioFire® Respiratory Panel 2.1-EZ
2022
N/A
~360

Find a Location

Who is running the clinical trial?

Andrew MeltzerLead Sponsor
4 Previous Clinical Trials
804 Total Patients Enrolled
BioMérieuxIndustry Sponsor
59 Previous Clinical Trials
42,788 Total Patients Enrolled
1 Trials studying Viral Infections
200 Patients Enrolled for Viral Infections
Andrew Meltzer, MDPrincipal InvestigatorClinical Research Director, Department of Emergency Medicine
1 Previous Clinical Trials
24 Total Patients Enrolled
~105 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top